magnesium aspartate tetrahydrate,Magnesium amino acid chelate,Magnesium orotate,pyridoxine hydrochloride,Potassium aspartate - 搜索结果

aurum pharmaceutical limited - magnesium sulphate heptahydrate - solution for injection and concentrate for infusion - 50 percent weight/volume - electrolyte solutions; magnesium sulfate

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

magnesium sulfate 38.5% w/w cutaneous paste

foran healthcare limited, - magnesium sulfate dried - cutaneous paste - 38.5 percent weight/weight - other dermatologicals; magnesium sulfate

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

amclavox duo 500/125, amoxicillin (as trihydrate) 500 mg and clavulanic acid (as potassium) 125 mg tablets strip pack

micro labs pty ltd - potassium clavulanate, quantity: 151.917 mg; amoxicillin trihydrate, quantity: 573.892 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; dichloromethane; isopropyl alcohol; sodium starch glycollate; titanium dioxide; hypromellose; propylene glycol; purified talc; ethylcellulose - amclavox duo 500/125 tablets are indicated for short-term treatment of bacterial infections at the following sites when caused by sensitive organisms (refer to microbiology):,urinary tract infections (complicated and uncomplicated),lower respiratory tract infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis,upper respiratory tract infections, such as sinusitis, otitis media and recurrent tonsillitis.,skin and skin structure infection.,appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to amoxicillin and clavulanic acid tablets. however, when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. once these results are known, therapy should be adjusted if appropriate. the treatment of mixed infections caused by amoxicillin susceptible organisms and beta-lactamase producing organisms susceptible to amoxicillin and clavulanic acid tablets preparations should not require the addition of another antibiotic due to the amoxicillin content of these products.

美国 - 英文 - NLM (National Library of Medicine)

acetaminophen and codeine phosphate tablet

mckesson contract packaging - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - acetaminophen 300 mg